Literature DB >> 10339592

Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.

T L Hoffman1, C C LaBranche, W Zhang, G Canziani, J Robinson, I Chaiken, J A Hoxie, R W Doms.   

Abstract

We recently derived a CD4-independent virus from HIV-1/IIIB, termed IIIBx, which interacts directly with the chemokine receptor CXCR4 to infect cells. To address the underlying mechanism, a cloned Env from the IIIBx swarm (8x) was used to produce soluble gp120. 8x gp120 bound directly to cells expressing only CXCR4, whereas binding of IIIB gp120 required soluble CD4. Using an optical biosensor, we found that CD4-induced (CD4i) epitopes recognized by mAbs 17b and 48d were more exposed on 8x than on IIIB gp120. The ability of 8x gp120 to bind directly to CXCR4 and to react with mAbs 17b and 48d in the absence of CD4 indicated that this gp120 exists in a partially triggered but stable state in which the conserved coreceptor-binding site in gp120, which overlaps with the 17b epitope, is exposed. Substitution of the 8x V3 loop with that from the R5 virus strain BaL resulted in an Env (8x-V3BaL) that mediated CD4-independent CCR5-dependent virus infection and a gp120 that bound to CCR5 in the absence of CD4. Thus, in a partially triggered Env protein, the V3 loop can change the specificity of coreceptor use but does not alter CD4 independence, indicating that these properties are dissociable. Finally, IIIBx was more sensitive to neutralization by HIV-positive human sera, a variety of anti-IIIB gp120 rabbit sera, and CD4i mAbs than was IIIB. The sensitivity of this virus to neutralization and the stable exposure of a highly conserved region of gp120 suggest new strategies for the development of antibodies and small molecule inhibitors to this functionally important domain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10339592      PMCID: PMC26886          DOI: 10.1073/pnas.96.11.6359

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.

Authors:  D Weissman; R L Rabin; J Arthos; A Rubbert; M Dybul; R Swofford; S Venkatesan; J M Farber; A S Fauci
Journal:  Nature       Date:  1997-10-30       Impact factor: 49.962

2.  Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry.

Authors:  J Rucker; B J Doranz; A L Edinger; D Long; J F Berson; R W Doms
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

3.  Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein.

Authors:  J Cao; N Sullivan; E Desjardin; C Parolin; J Robinson; R Wyatt; J Sodroski
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain.

Authors:  A L Edinger; J L Mankowski; B J Doranz; B J Margulies; B Lee; J Rucker; M Sharron; T L Hoffman; J F Berson; M C Zink; V M Hirsch; J E Clements; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection.

Authors:  B Chackerian; E M Long; P A Luciw; J Overbaugh
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.

Authors:  S L Kozak; E J Platt; N Madani; F E Ferro; K Peden; D Kabat
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.

Authors:  R F Speck; K Wehrly; E J Platt; R E Atchison; I F Charo; D Kabat; B Chesebro; M A Goldsmith
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.

Authors:  C M Hill; H Deng; D Unutmaz; V N Kewalramani; L Bastiani; M K Gorny; S Zolla-Pazner; D R Littman
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype.

Authors:  J Dumonceaux; S Nisole; C Chanel; L Quivet; A Amara; F Baleux; P Briand; U Hazan
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5.

Authors:  C B Davis; I Dikic; D Unutmaz; C M Hill; J Arthos; M A Siani; D A Thompson; J Schlessinger; D R Littman
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  128 in total

1.  Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.

Authors:  A L Edinger; M Ahuja; T Sung; K C Baxter; B Haggarty; R W Doms; J A Hoxie
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Energetics of the HIV gp120-CD4 binding reaction.

Authors:  D G Myszka; R W Sweet; P Hensley; M Brigham-Burke; P D Kwong; W A Hendrickson; R Wyatt; J Sodroski; M L Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 3.  Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

Authors:  J Overbaugh; A D Miller; M V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

4.  Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.

Authors:  Terri G Edwards; Stéphanie Wyss; Jacqueline D Reeves; Susan Zolla-Pazner; James A Hoxie; Robert W Doms; Frédéric Baribaud
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors.

Authors:  T L Hoffman; G Canziani; L Jia; J Rucker; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

6.  The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.

Authors:  S W Barnett; S Lu; I Srivastava; S Cherpelis; A Gettie; J Blanchard; S Wang; I Mboudjeka; L Leung; Y Lian; A Fong; C Buckner; A Ly; S Hilt; J Ulmer; C T Wild; J R Mascola; L Stamatatos
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

7.  Membrane fusion mediated by coiled coils: a hypothesis.

Authors:  J Bentz
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

8.  Blocking the docking of HIV-1.

Authors:  Aine McKnight; Robin A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

9.  Late-emerging strains of HIV induce T-cell homeostasis failure by promoting bystander cell death and immune exhaustion in naïve CD4 and all CD8 T-cells.

Authors:  Catherine N Kibirige; Frederick A Menendez; Hao Zhang; Tricia L Nilles; Susan Langan; Joseph B Margolick
Journal:  Med Hypotheses       Date:  2014-04-13       Impact factor: 1.538

10.  Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.

Authors:  Aran F Labrijn; Pascal Poignard; Aarti Raja; Michael B Zwick; Karla Delgado; Michael Franti; James Binley; Veronique Vivona; Christoph Grundner; Chih-Chin Huang; Miro Venturi; Christos J Petropoulos; Terri Wrin; Dimiter S Dimitrov; James Robinson; Peter D Kwong; Richard T Wyatt; Joseph Sodroski; Dennis R Burton
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.